Author:
Liu Di,Cao Jingxue,Ding Xi,Xu Wen,Yao Xiaojuan,Dai Mengyuan,Tai Qidong,Shi Minxing,Fei Ke,Xu Yaping,Su Bo
Funder
Shanghai Municipality Science and Technology Commission
National Natural Science Foundation of China
Reference43 articles.
1. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;ME,2024
2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008
3. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
4. p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients;Murakami;Clin. Cancer Res.,2000
5. p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study;Ahrendt;J. Natl. Cancer Inst.,2003